Free Trial

Deerfield Management Company L.P. Series C Decreases Stake in Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background

Deerfield Management Company L.P. Series C reduced its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 92.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 10,194 shares of the company's stock after selling 126,951 shares during the period. Deerfield Management Company L.P. Series C's holdings in Nu Skin Enterprises were worth $70,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. bought a new position in shares of Nu Skin Enterprises during the 4th quarter worth $25,000. US Bancorp DE raised its position in shares of Nu Skin Enterprises by 424.2% in the fourth quarter. US Bancorp DE now owns 7,460 shares of the company's stock worth $51,000 after buying an additional 6,037 shares in the last quarter. Signaturefd LLC increased its position in shares of Nu Skin Enterprises by 536.8% in the fourth quarter. Signaturefd LLC now owns 8,087 shares of the company's stock worth $56,000 after purchasing an additional 6,817 shares during the last quarter. PNC Financial Services Group Inc. grew its position in Nu Skin Enterprises by 2,412.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company's stock worth $57,000 after acquiring an additional 7,888 shares in the last quarter. Finally, Bank of Montreal Can purchased a new position in Nu Skin Enterprises in the fourth quarter worth $80,000. 82.84% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th.

View Our Latest Stock Report on Nu Skin Enterprises

Nu Skin Enterprises Trading Up 9.1%

NUS traded up $0.63 during trading on Monday, hitting $7.47. 1,319,188 shares of the stock traded hands, compared to its average volume of 838,900. The firm has a 50-day moving average of $6.73 and a 200 day moving average of $6.95. The firm has a market capitalization of $371.18 million, a P/E ratio of -2.53 and a beta of 0.92. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. Nu Skin Enterprises, Inc. has a 12-month low of $5.32 and a 12-month high of $14.00.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The business had revenue of $364.49 million for the quarter, compared to the consensus estimate of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Equities research analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Friday, May 30th will be given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.22%. The ex-dividend date is Friday, May 30th. Nu Skin Enterprises's dividend payout ratio is currently -30.00%.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Read More

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines